Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    From $11.99/month after trial. Cancel anytime.

    Virologic Failure in HIV: An Updated Clinician’s Guide to Assessment and Management
    Virologic Failure in HIV: An Updated Clinician’s Guide to Assessment and Management
    Virologic Failure in HIV: An Updated Clinician’s Guide to Assessment and Management
    Ebook61 pages34 minutes

    Virologic Failure in HIV: An Updated Clinician’s Guide to Assessment and Management

    By Jürgen Rockstroh, MD and David Wohl, MD

    ()

    Read preview

    About this ebook

    Though the prevalence of virologic failure (VF) in patients with HIV has decreased as newer antiretroviral (ART) regimens with higher genetic barriers to resistance and reduced toxicity have been approved, VF can still occur. VF may be due to patient, viral, or ART factors, and it is critical that clinicians determine the underlying cause before switching ART regimens so they can work with the patient to select the most appropriate regimen. Resistance will affect selection of subsequent regimens for patients experiencing VF, particularly among those with multidrug resistance (MDR). All patients experiencing VF should undergo resistance testing, and clinicians should engage in shared decision-making when selecting ART regimens, to ensure the patient can be adherent.  


    Heavily treatment-experienced (HTE) patients with MDR have had few options specifically designed to supplement an optimized background regimen, but these options have expanded over the last several years, and there is hope that this small subset of patients will have even more options in the future. In this eHealth activity, Drs David Wohl and Jürgen Rockstroh discuss evaluation of VF, selection of subsequent regimens for patients experiencing VF, and recently approved and emerging options for HTE patients,  including how to create and simplify salvage regimens for these patients.

    LanguageEnglish
    PublisherIntegritas Communications
    Release dateJun 10, 2022
    Virologic Failure in HIV: An Updated Clinician’s Guide to Assessment and Management

    Related to Virologic Failure in HIV

    Related ebooks

    Teaching Methods & Materials For You

    View More
    View More

    Related podcast episodes

    Related articles

    • UNLIMITED

      Mother Earth News

      Jul 12, 2024

      Mother Earth News
      7 min read

    • UNLIMITED

      January 2023

      Nov 23, 2022

      January 2023
      2 min read

    • UNLIMITED

      PFAS FOREVER CHEMICALS Above Drinking Water Level Guidelines In Global Source

      May 25, 2024

      Per-and poly-fluoroalkyl substances -commonly known as PFAS – are a group of over 14,000 human-made chemicals that have been popular since the 1950s for their diverse uses in resisting heat, water, grease and stains. They’ve been commonly found in ho

      1 min read

    • UNLIMITED

      Detox

      Dec 17, 2021

      Detox
      1 min read

    • UNLIMITED

      GROWING IN THE shadows

      Apr 18, 2023

      GROWING IN THE shadows
      3 min read

    • UNLIMITED

      Federal Judge Rules Clinical Trial Sponsors Must Publish A Decade’s Worth Of Missing Data

      Feb 25, 2020

      The ruling means universities, drug makers, and medical device manufacturers must publish data collected in clinical trials conducted between 2007 and 2017.

      2 min read

    • UNLIMITED

      Skin & Hair Care JOJOBA OIL

      Feb 1, 2024

      Skin & Hair Care JOJOBA OIL
      4 min read

    • UNLIMITED

      The World’s Best Hospitals2023

      Mar 10, 2023

      The World’s Best Hospitals2023
      9 min read

    • UNLIMITED

      Safer Blood Products: One Researcher’s Story on Why Federal Support Matters

      Apr 12, 2017

      In 1982, a crisis was beginning to unfold. Gay men were dying of an unknown cause, which years later was shown to be the Human Immunodeficiency Virus (HIV).  At that time, I was not involved with the gay community, with acquired immunodeficiency synd

      3 min read

    • UNLIMITED

      Alleviation Before Cure

      Apr 23, 2020

      Alleviation Before Cure
      3 min read

    • UNLIMITED

      Plan Cuts Mortality For People With HIV Who Inject Drugs

      Sep 12, 2018

      A new intervention for people living with HIV who inject drugs led to an increase in people taking their medications and a decrease in mortality, according to new research. The integrated intervention combines counseling, substance use treatment, and

      2 min read

    • UNLIMITED

      COVID-19: Risk Assessment & Mitigation Strategy

      Nov 6, 2020

      Aster DM Healthcare has been at the epicentre of managing COVID-19 pandemic in India and Gulf Cooperation Council countries ever since the pandemic hit in mid-March. This paper is a fascinating organisational case study and report about how Aster DM

      11 min read

    Related categories

    Reviews for Virologic Failure in HIV

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Virologic Failure in HIV - Jürgen Rockstroh, MD

      Faculty

      Jürgen Rockstroh, MD

      Professor of Medicine

      Head of the HIV Outpatient Clinic

      University of Bonn

      Bonn, Germany

      Jürgen Rockstroh, MD, is Professor of Medicine and Head of the HIV Outpatient Clinic at the University of Bonn in Germany. He earned his Doctor of Medicine degree from the Rheinische Friedrich-Wilhelms University of Bonn and completed his residency in the Department of Medicine at the University of Bonn. His department treats the world’s largest cohort of HIV-infected patients with hemophilia.

      In addition to his clinical practice, Dr Rockstroh is involved in HIV research on antiretroviral therapy (ART), including new drug classes; the course of HIV disease in patients with hemophilia; and HIV and hepatitis co-infection. More recently, he has begun working on the impact of COVID-19 on HIV co-infection. He has been an investigator in multiple clinical trials of ART agents and treatments for HIV, hepatitis co-infection, and COVID-19.

      From 2007 to 2011 he served as president of the German AIDS Society. Since 2009, he has been a member of the executive committee of the European AIDS Clinical Society (EACS), and from 2011 to 2020 was a member of the governing council of the International AIDS Society. He was chair of the National German AIDS Advisory Panel from  2011 to 2017 and of the EACS co-infection guidelines committee from 2008 to 2017. In 2015, Professor Rockstroh was elected chair of HIV in Europe (in 2019 renamed as EuroTEST), and in 2019-2020 was president of EACS.

      The German Society for Infectious Diseases awarded Dr Rockstroh and his co-authors the prize in clinical infectious diseases in 2002 and the national AIDS research prize in 2005. Dr Rockstroh has authored or co-authored more than 700 publications in peer-reviewed journals and more than 100 book chapters.

      David A. Wohl, MD

      Professor of Medicine

      Co-Principal Investigator, Global Infectious Disease Clinical Research Unit

      Co-Director, Viral Hemorrhagic Fever Clinical Research Group and UNC Project Liberia

      Institute for Global Health & Infectious Diseases

      The University of North Carolina at Chapel Hill School of Medicine

      Chapel Hill, North Carolina

      Dr Wohl is a Professor of Medicine in the Division of Infectious Diseases at the University of North Carolina (UNC). He is co-Principal Investigator of the Global UNC Infectious Diseases Clinical Research Unit and Site Leader of its Chapel Hill research site.

      Dr Wohl is a clinical scientist with a focus on emergent infectious diseases. He has spent more than 20 years leading research into the prevention and treatment of HIV and served 2 terms as a member of the US Department of Health and Human Services Antiretroviral Guidelines Panel.

      Since 2014, he has been working continuously in Liberia, West Africa, conducting research with survivors of Ebola to learn about chronic complications and sexual transmission of this infection and establishing the UNC Project Liberia research platform at 2 locations in the country. He and

      Enjoying the preview?
      Page 1 of 1